clinical cancer research : an official journal of the american association for cancer research2020Vol. 26pp. -
267
pt2020clinicaleverolimus,
Abstract
Everolimus, letrozole, and metformin resulted in 50% CB and 28% OR in women with recurrent EEC. Progesterone receptor-positive tumors may have better response; validation studies are needed.See related commentary by Madariaga et al., p. 523.